European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrices.
暂无分享,去创建一个
Nicholas Gray | Clare Kingsley | Stephen White | Benno Ingelse | Begona Barroso | Verena Jakob-Rodamer | Corinna Sykora | Petra Vinck | Martina Wein | B. Barroso | Steve White | Benno Ingelse | N. Gray | C. Sykora | Petra Vinck | Verena Jakob-Rodamer | Clare Kingsley | M. Wein
[1] J. Foley,et al. Reduction in matrix-related signal suppression effects in electrospray ionization mass spectrometry using on-line two-dimensional liquid chromatography. , 2001, Analytical chemistry.
[2] Fabio Garofolo,et al. Bioanalytical Method Validation , 2004 .
[3] Heather Myler,et al. Large Molecule Specific Assay Operation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team , 2013, The AAPS Journal.
[4] B. Matuszewski,et al. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. , 1998, Analytical chemistry.
[5] Binodh DeSilva,et al. Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.
[6] Fabio Garofolo,et al. Impact of sample hemolysis on drug stability in regulated bioanalysis. , 2011, Bioanalysis.
[7] S. Kazmierczak. Hemolysis, Lipemia, and High Bilirubin: Effect on Laboratory Tests , 2013 .
[8] W. Weinmann,et al. Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] Nora Nikolac,et al. Lipemia: causes, interference mechanisms, detection and management , 2014, Biochemia medica.
[10] Philip Timmerman,et al. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. , 2013, Bioanalysis.
[11] Hemolysis of Blood Samples has no Significant Impact on the Results of Pharmacokinetic Data , 2012 .
[12] R. Vries,et al. Aging of biological matrices and its effect on bioanalytical method performance , 2013 .
[13] M. I. Maguregui,et al. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. , 2014, Journal of chromatography. A.
[14] W. Price,et al. Using calibration approaches to compensate for remaining matrix effects in quantitative liquid chromatography/electrospray ionization multistage mass spectrometric analysis of phytoestrogens in aqueous environmental samples. , 2007, Rapid communications in mass spectrometry : RCM.
[15] Erin Chambers,et al. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] Milton Furtado,et al. Severe impact of hemolysis on stability of phenolic compounds. , 2013, Bioanalysis.
[17] W. Lambert,et al. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.
[18] H Kenneth Walker,et al. Clinical methods: The history, physical, and laboratory examinations , 1976 .
[19] S. Gagné,et al. Impact of hemolysis during sample collection: how different is drug concentration in hemolyzed plasma from that of normal plasma? , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] Nicola C Hughes,et al. Assessing the matrix effects of hemolyzed samples in bioanalysis. , 2009, Bioanalysis.